COMMUNIQUÉS West-GlobeNewswire
-
ABLYNX ESTABLISHES SUBSIDIARY IN THE USA AND APPOINTS A GENERAL MANAGER
16/10/2017 - 07:00 -
INNATE PHARMA : IPH4102: Final results of the dose-escalation part of the Phase I study
16/10/2017 - 07:00 -
INNATE PHARMA : IPH4102: Résultats finaux de la partie escalade de dose de l'étude de Phase I
16/10/2017 - 07:00 -
World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines
15/10/2017 - 09:47 -
MITHRA ANNOUNCES COMPLETION OF RECRUITMENT IN DONESTA® PHASE II STUDY
13/10/2017 - 23:00 -
Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation
13/10/2017 - 16:00 -
Novavax Announces Leadership Change
13/10/2017 - 13:30 -
Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes
13/10/2017 - 13:30 -
Summit Therapeutics plc : Holding(s) in Company
13/10/2017 - 10:10 -
AroCell AB: announces that a distribution agreement has been signed with Pathway Diagnostics Ltd, for distribution of the AroCell TK 210 ELISA test in United Kingdom and Ireland.
13/10/2017 - 08:50 -
Solon Eiendom ASA : Primary insider notification
13/10/2017 - 08:30 -
Nouveau logo, nouvelle charte, Medasys adopte une nouvelle identité visuelle
13/10/2017 - 08:30 -
Shire plc : New Formulation of ONCASPAR® (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)
13/10/2017 - 08:04 -
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
13/10/2017 - 07:00 -
Bone Therapeutics SA : The preliminary documents for the Extraordinary General Shareholder Meeting on 30 October 2017 have been made available
13/10/2017 - 07:00 -
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 30 octobre 2017
13/10/2017 - 07:00 -
Medibio completes heavily oversubscribed institutional placement for $13.9 million to accelerate commercialisation
13/10/2017 - 04:00 -
JFR 2017 - Medasys s'associe à Infinitt Healthcare pour répondre aux besoins de partage territoriaux de contenus cliniques et continuer la transformation des métiers en imagerie
12/10/2017 - 19:11 -
ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®
12/10/2017 - 18:00
Pages